News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Tambi Brian
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/13/2019 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 30,760 shares
@ $0 Granted 58,775 options to buy
@ $4.47, valued at
$262.7k
|
|
05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/23/2018 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 14,189 shares
@ $0 |
|
11/22/2017 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Sold 15,100 shares
@ $33.35, valued at
$503.6k
|
|
08/09/2017 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Sold 5,165 shares
@ $33.37, valued at
$172.4k
|
|
05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/23/2017 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc. |
07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2016 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Sold 25,000 shares
@ $30.73, valued at
$768.3k
Exercised 25,000 options to buy
@ $2.61, valued at
$65.3k
Exercised 25,000 options to buy
@ $6.62, valued at
$165.5k
|
|
05/04/2016 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $14.44, valued at
$361k
|
|
05/27/2015 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Sold 1,800 shares
@ $60, valued at
$108k
Sold 3,100 shares
@ $60.09, valued at
$186.3k
Exercised 1,800 options to buy
@ $1.22, valued at
$2.2k
Exercised 3,100 options to buy
@ $1.22, valued at
$3.8k
|
|
05/22/2015 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Disposed/sold 25,000 options to buy
@ $2.61, valued at
$65.3k
Granted 25,000 options to buy
@ $2.61, valued at
$65.3k
|
|
05/20/2015 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Exercised 1,200 shares
@ $1.22, valued at
$1.5k
Sold 1,200 shares
@ $60.01, valued at
$72k
Sold 3,900 shares
@ $60.14, valued at
$234.5k
Exercised 1,200 options to buy
@ $0 Exercised 3,900 options to buy
@ $1.22, valued at
$4.8k
|
|
05/07/2015 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Granted 9,000 options to buy
@ $53.5, valued at
$481.5k
|
|
12/16/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Sold 1,200 shares
@ $41.86, valued at
$50.2k
|
|
09/15/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Sold 13,800 shares
@ $38, valued at
$524.4k
Exercised 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
09/09/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 8,034 shares
@ $38.16, valued at
$306.6k
|
|
09/09/2014 |
4/A
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
08/11/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Granted 9,000 options to buy
@ $27.14, valued at
$244.3k
|
|
06/16/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Bought 1,000 shares
@ $27.62, valued at
$27.6k
|
|
05/06/2014 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 10,753 options to buy
@ $24.74, valued at
$266k
|
|
05/16/2013 |
4
| Tambi Brian (Director) has filed a Form 4 on Insys Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $10.89, valued at
$217.8k
|
|
05/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/14/2012 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 5,000 shares
@ $0 |
|
05/25/2010 |
4
| Tambi Brian (Director) has filed a Form 4 on AKORN INC
Txns:
| Granted 25,000 options to buy
@ $2.61, valued at
$65.3k
|
|
08/11/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
07/07/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|